Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Thierry Facon, MD, Jesús San-Miguel, Saad Z. Usmani, MD, Meletios A. Dimopoulos, MD, Shaji K. Kumar, MD, Maria-Victoria Mateos, Michele Cavo, Bart Heeg, PhD, Sophie Van Beekhuizen, MSc, Marta Pisini, MBA, Sandhya Nair, Annette Lam, BSc, MSc, Mary Slavcev, Jianming He, PhD

Blood (2019) 134 (Supplement_1): 2144.

https://doi.org/10.1182/blood-2019-123561

Published: 2019

Journal Articles

Profile of Myeloproliferative Neoplasms in Kuwait: Population-Based Study

Mazyad Jamal Almazyad, Aisha S Alwehaib, Salem Alshemmari, MDFRCPC

Blood (2019) 134 (Supplement_1): 5373.

https://doi.org/10.1182/blood-2019-128536

Published: 2019

Journal Articles

A State Level Retrospective Analysis of Newborn Screening for Hemoglobinopathies

Maryam Gbadamosi-Akindele, MD, Sarah Aurit, Amissabah Johnson, Alex Nester, MD

Blood (2019) 134 (Supplement_1): 5806.

https://doi.org/10.1182/blood-2019-122039

Published: 2019

Journal Articles

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Miranda Bailey, Megan Gibbs, Nidhi Dani, Ari Mendell, Melissa Thompson

Blood (2019) 134 (Supplement_1): 5867.

https://doi.org/10.1182/blood-2019-131699

Published: 2019

Journal Articles

An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

Blood (2019) 134 (Supplement_1): 2305.

https://doi.org/10.1182/blood-2019-127613

Published: 2019

Journal Articles

Imerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) That Is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Blood (2019) 134 (Supplement_1): 4248.

https://doi.org/10.1182/blood-2019-127435

Published: 2019

Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg

Blood (2018) 132 (Supplement 1): 2917.

https://doi.org/10.1182/blood-2018-99-111146

Published: 2018

Journal Articles

Risk-Benefit and Cost-Effectiveness of Universal Iron Interventions for Public Health Control of Anemia in Young Children in 78 Countries: A Microsimulation Study

Sant-Rayn Pasricha, MD PhD, Adrian Gheorghe, PhD, Fayrouz Ashour, Amrita Arcot, BS, Laura E Murray-Kolb, PhD, Parmi Suchdev, MD MPH, Michael Bode, PhD

Blood (2018) 132 (Supplement 1): 2276.

https://doi.org/10.1182/blood-2018-99-117611

Published: 2018

Journal Articles

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Mohamed A Yassin, Ali Taher, MD PhD, Vikram Mathews, MD, Hsin-An Hou, MD PhD, Tahir Shamsi, Tulin Tuglular, MD, Zhijian Xiao, Soo-Jeong Kim, MD, Depei Wu, MD PhD, Junmin Li, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD

Blood (2018) 132 (Supplement 1): 5461.

https://doi.org/10.1182/blood-2018-99-114416

Published: 2018

Journal Articles

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Ali Taher, MD PhD, Mohamed A Yassin, Zhijian Xiao, Hsin-An Hou, MD PhD, Tulin Tuglular, MD, Vikram Mathews, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD

Blood (2018) 132 (Supplement 1): 4311.

https://doi.org/10.1182/blood-2018-99-113248

Published: 2018

Journal Articles

Quality of Life Among Adolescents with Beta-Thalassemia Major (TM) in Qatar

Abdulqadir Jeprel Nashwan, BSN, MSN, RN, CBT-HMS, Mohamed A Yassin, MBBS, MSc, Ganga Babu, Sindhumole LK Nair, Izette Libo-on, Hothaifah Hijazi, Vincenzo De Sanctis, Ashraf Tawfiq Soliman, MD PhD

Blood (2018) 132 (Supplement 1): 4906.

https://doi.org/10.1182/blood-2018-99-114427

Published: 2018

Journal Articles

Iron Chelation Therapy of Thalassemia Patients Is Still a Challenge. Single Centre Experience from United Arab Emirates

Hani Yousif Osman, MD, Khaled al Qawasmeh, Sabir Hussain, MBBS FRCP, Amar Lal, MBBS FCPS MRCP, Arif Alam, Jorgen Kristensen, MD PhD

Blood (2018) 132 (Supplement 1): 4908.

https://doi.org/10.1182/blood-2018-99-114601

Published: 2018

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Community Survey of Knowledge of Thalassemia

Jin Mei, BA, Robert Yamashita, PhD, Ashutosh Lal, MD, Nancy F. Olivieri, MD, Elliott Vichinsky, MD

Blood (2017) 130 (Supplement 1): 5580.

https://doi.org/10.1182/blood.V130.Suppl_1.5580.5580

Published: 2017

Journal Articles

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

Alexander G. G. Turpie, MD, Lorenzo G Mantovani, Sylvia Katharina Haas, MD PhD, Reinhold Kreutz, PhD, Danja Monje, Jonas Schneider, Martin van Eickels, Miriam Tamm, Martin Gebel, Walter Ageno

Blood (2017) 130 (Supplement 1): 2386.

https://doi.org/10.1182/blood.V130.Suppl_1.2386.2386

Published: 2017

Journal Articles

International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data

Beng H Chong, MBBS, PhD, Jong-Wook Lee, MD, Jun Ho Jang, MD PhD, Tzeon-Jye Chiou, MD, Lai Heng Lee, Osman Ilhan, MD, Pantep Angchaisuksiri, MD, Ai-Sim Goh, Soo Chin Ng, FRCP, Shinichiro Okamoto, MD, Kenny Mauricio Galvez, Sarah Davidson, RN

Blood (2017) 130 (Supplement 1): 4853.

https://doi.org/10.1182/blood.V130.Suppl_1.4853.4853

Published: 2017

Journal Articles

An Observational, Non-Interventional, Multicentre Study of Immune Thrombocytopenia: The Africa Middle East and Asian Immune Thrombocytopenia Registry

Faisal Alsayegh, BMBCH, Mohammed Qari, Mervat Matar, Yasser Wali, Muhammad Kanani, Ali Al Madhani, Ibrahim Al Hijji, Doaa El Demerdash, Mahmoud Abbas

Blood (2017) 130 (Supplement 1): 4861.

https://doi.org/10.1182/blood.V130.Suppl_1.4861.4861

Published: 2017

Journal Articles

ITP Patients in the Asia Pacific: Are They Different?

Beng H Chong, MBBS, PhD, Jong-Wook Lee, MD, Jun Ho Jang, MD PhD, Tzeon-Jye Chiou, MD, Lai Heng Lee, Osman Ilhan, MD, Pantep Angchaisuksiri, MD, Kenny Mauricio Galvez, Ai-Sim Goh, Soo Chin Ng, FRCP, Shinichiro Okamoto, MD, Sarah Davidson, RN

Blood (2017) 130 (Supplement 1): 4862.

https://doi.org/10.1182/blood.V130.Suppl_1.4862.4862

Published: 2017

Journal Articles

Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

Saad Akhtar, MD, Amani Al-Kofide, MD, Nasir Bakshi, MD, Mohammed Shamayel, MD, Yasser Khafaga, MD, Suleimman Al-Sweedan, MD, Tusneem Elhassan, MSc, M S Rauf, MD, Irfan Maghfoor, MD

Blood (2017) 130 (Supplement 1): 2794.

https://doi.org/10.1182/blood.V130.Suppl_1.2794.2794

Published: 2017

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

NARROW

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Profile of Myeloproliferative Neoplasms in Kuwait: Population-Based Study

A State Level Retrospective Analysis of Newborn Screening for Hemoglobinopathies

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

Imerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) That Is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Risk-Benefit and Cost-Effectiveness of Universal Iron Interventions for Public Health Control of Anemia in Young Children in 78 Countries: A Microsimulation Study

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Quality of Life Among Adolescents with Beta-Thalassemia Major (TM) in Qatar

Iron Chelation Therapy of Thalassemia Patients Is Still a Challenge. Single Centre Experience from United Arab Emirates

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Community Survey of Knowledge of Thalassemia

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data

An Observational, Non-Interventional, Multicentre Study of Immune Thrombocytopenia: The Africa Middle East and Asian Immune Thrombocytopenia Registry

ITP Patients in the Asia Pacific: Are They Different?

Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only